journal article·2021Open access

Employing defined bioconjugates to generate chemically functionalised gold nanoparticles for in vitro diagnostic applications

Daniel A. Richards, Michael R. Thomas, Peter A. Szijj, James Foote, Yiyun Chen, João C. F. Nogueira, Vijay Chudasama, Molly M. Stevens

Nanoscale· Volume 13· Issue 27

Abstract

Novel methods for introducing chemical and biological functionality to the surface of gold nanoparticles serve to increase the utility of this class of nanomaterials across a range of applications. To date, methods for functionalising gold surfaces have relied upon uncontrollable non-specific adsorption, bespoke chemical linkers, or non-generalisable protein-protein interactions. Herein we report a versatile method for introducing functionality to gold nanoparticles by exploiting the strong interaction between chemically functionalised bovine serum albumin (f-BSA) and citrate-capped gold nanoparticles (AuNPs). We establish the generalisability of the method by introducing a variety of functionalities to gold nanoparticles using cheap, commercially available chemical linkers. The utility of this approach is further demonstrated through the conjugation of the monoclonal antibody Ontruzant to f-BSA-AuNPs using inverse electron-demand Diels-Alder (iEDDA) click chemistry, a hitherto unexplored chemistry for AuNP-IgG conjugation. Finally, we show that the AuNP-Ontruzant particles generated via f-BSA-AuNPs have a greater affinity for their target in a lateral flow format when compared to conventional physisorption, highlighting the potential of this technology for producing sensitive diagnostic tests.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Materials, Imperial College London, London, UK

Department of Bioengineering, Imperial College London, UK

Institute of Biomedical Engineering, Imperial College London, London, UK

London Centre for Nanotechnology, University College London, London, UK

Department of Biochemical Engineering, University College London, WC1E 6BT London, UK

Department of Chemistry, University College London, London, UK

Department of Medical Biochemistry and Biophysics, Stockholm, Sweden

Funding

Cancer Research UK · Wellcome Trust · H2020 Marie Skłodowska-Curie Actions · Engineering and Physical Sciences Research Council · Rosetrees Trust

References (43)

Show source-provided references
1. Yao · Chem. Rev. · 2014 · 114 · 613010.1021/cr200359p ↗
2. Hua · Front. Pharmacol. · 2018 · 9 · 110.3389/fphar.2018.00001 ↗
3. Howes · Science · 2014 · 346 · 124739010.1126/science.1247390 ↗
4. Loynachan · ACS Nano · 2018 · 12 · 27910.1021/acsnano.7b06229 ↗
5. Lee · Korean J. Chem. Eng. · 2018 · 35 · 110.1007/s11814-017-0236-5 ↗
6. Fathi-Achachelouei · Front. Bioeng. Biotechnol. · 2019 · 7 · 110.3389/fbioe.2019.00113 ↗
7. Biju · Chem. Soc. Rev. · 2014 · 43 · 74410.1039/C3CS60273G ↗
8. Yeh · Nanoscale · 2012 · 4 · 187110.1039/C1NR11188D ↗
9. Polavarapu · Nanotechnology · 2009 · 20 · 18560610.1088/0957-4484/20/18/185606 ↗
10. Walkey · ACS Nano · 2014 · 8 · 243910.1021/nn406018q ↗
11. Murthy · J. Am. Chem. Soc. · 2013 · 135 · 779910.1021/ja400701c ↗
12. Zhao · Biomater. Sci. · 2018 · 6 · 20010.1039/C7BM00747G ↗
13. Chen · Acc. Chem. Res. · 2017 · 50 · 31010.1021/acs.accounts.6b00506 ↗
14. D'Agata · Beilstein J. Nanotechnol. · 2017 · 8 · 110.3762/bjnano.8.1 ↗
15. Tripathi · ACS Omega · 2018 · 3 · 825310.1021/acsomega.8b00591 ↗
16. James · Analyst · 2013 · 121210.1039/c2an36467k ↗
17. Liu · Talanta · 2019 · 194 · 66410.1016/j.talanta.2018.10.079 ↗
18. Ma · Nat. Commun. · 2018 · 9 · 110.1038/s41467-017-02088-w ↗
19. Wu · Front. Chem. · 2020 · 8 · 110.3389/fchem.2020.00001 ↗
20. Bolaños · Int. J. Nanomed. · 2019 · 14 · 638710.2147/IJN.S210992 ↗
21. Brewer · Langmuir · 2005 · 21 · 930310.1021/la050588t ↗
22. Knall · Chem. Soc. Rev. · 2013 · 42 · 513110.1039/c3cs60049a ↗
23. Brand · ChemistryOpen · 2017 · 6 · 61510.1002/open.201700105 ↗
24. Wall · Org. Biomol. Chem. · 2019 · 17 · 787010.1039/C9OB00721K ↗
25. Rossin · Mol. Pharm. · 2014 · 11 · 309010.1021/mp500275a ↗
26. Rossin · Bioconjugate Chem. · 2013 · 24 · 121010.1021/bc400153y ↗
27. Tsai · Langmuir · 2011 · 27 · 246410.1021/la104124d ↗
28. Roy · Polyhedron · 2016 · 115 · 11110.1016/j.poly.2016.05.002 ↗
29. Shi · Chin. Sci. Bull. · 2012 · 57 · 110910.1007/s11434-011-4741-3 ↗
30. Casals · ACS Nano · 2010 · 4 · 362310.1021/nn901372t ↗
31. Byzova · Bioconjugate Chem. · 2017 · 28 · 273710.1021/acs.bioconjchem.7b00489 ↗
32. Safenkova · Anal. Bioanal. Chem. · 2012 · 403 · 159510.1007/s00216-012-5985-8 ↗
33. Choi · Clin. Chim. Acta · 2004 · 339 · 14710.1016/j.cccn.2003.10.002 ↗
34. Michelet · Clin. Chem. · 1995 · 41 · 150910.1093/clinchem/41.10.1509 ↗
35. Salazar · J. Chromatogr. Sci. · 1999 · 37 · 46910.1093/chromsci/37.12.469 ↗
36. Look · Eur. J. Clin. Nutr. · 1997 · 51 · 26610.1038/sj.ejcn.1600401 ↗
37. Richards · Chem. Sci. · 2017 · 8 · 6310.1039/C6SC02403C ↗
38. Maruani · Bioconjugate Chem. · 2020 · 31 · 52010.1021/acs.bioconjchem.0c00002 ↗
39. Bahou · Org. Biomol. Chem. · 2018 · 16 · 135910.1039/C7OB03138F ↗
40. Greene · Chem. Sci. · 2018 · 9 · 7910.1039/C7SC02747H ↗
41. Nogueira · Chem. Commun. · 2019 · 55 · 767110.1039/C9CC02655J ↗
42. Greene · Nanoscale · 2020 · 12 · 1164710.1039/D0NR02387F ↗
43. Robinson · RSC Adv. · 2017 · 7 · 907310.1039/C7RA00788D ↗